Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Suliman A. Alsagaby"'
Autor:
Suliman A. Alsagaby
Publikováno v:
Stem Cells International, Vol 2021 (2021)
Stem Cells International
Stem Cells International
Hematologic cancer encompasses the heterogeneous group of neoplasms that affect different stages of blood cell linages. Despite the significant improvements made in the new modalities of anticancer therapy, many forms of blood cancer remain untreatab
Autor:
Christopher Fegan, Suliman A. Alsagaby, Chris Pepper, Mariappan Premanathan, Rajendran Vijayakumar, Waleed Al Abdulmonem, Ian Andrew Brewis, Ameen S. S. Alwashmi, Fahad A. Alhumaydhi, Naif Khalaf Alharbi, Paul Brennan, Guy Pratt
Publikováno v:
Electronic Journal of Biotechnology, Vol 52, Iss, Pp 1-12 (2021)
Background: Chronic lymphocytic leukaemia (CLL) is a neoplasm of B-cells characterized by variable prognosis. Exploring the proteome of CLL cells may provide insights into the disease. Therefore, eleven proteomics experiments were conducted on eleven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c80e3dbceb18e898d829d9a945885230
http://sro.sussex.ac.uk/id/eprint/108223/1/1-s2.0-S071734582100021X-main.pdf
http://sro.sussex.ac.uk/id/eprint/108223/1/1-s2.0-S071734582100021X-main.pdf
Autor:
Saleh Althenayyan, Mohammed H AlMuhanna, Abdulkareem Al Abdulrahman, Bandar Alghanem, Suliman A. Alsagaby, Mohammad Aziz
Colorectal cancer prognosis get worse with advancement of disease into metastatic stage. There is a pertinent need to develop prognostic biomarkers that can be used for personalized and precision medicine. Alternative splicing provides an insight int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f9d4a29c46f200d6176c1812d7c7f4
https://doi.org/10.20944/preprints202106.0102.v2
https://doi.org/10.20944/preprints202106.0102.v2
Autor:
Vishnu Priya Veeraraghavan, Mohammed Saleh Al Aboody, Suresh Mickymaray, Yang Ke, Suliman A. Alsagaby, Wael Alturaiki, Faiz Abdulaziz Alfaiz
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology. 47:1938-1946
Bionanotechnology has pivotal role in the development of a novel therapy, applications of gold nanoparticles (AuNPs) in the treatment of cancer. In this study, we found that therapeutics, pharmaceutics and diagnostic effectiveness of photosynthesized
Autor:
Suliman A. Alsagaby
Publikováno v:
Oncology Reviews, Vol 13, Iss 2 (2019)
Oncology Reviews
Oncology Reviews
B-lineage acute lymphoblastic leukemia (B-ALL) is the most common type of cancer seen in children and is characterized by a variable clinical course. Although there have been remarkable improvements in the therapy outcomes of pediatric B-ALL, treatme
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:593-606
Chronic lymphocytic leukemia (CLL) is an adult neoplastic disease of B cells characterized by variable clinical outcomes. Although some patients have an aggressive form of the disease and often encounter treatment failure and short survival, others h
Autor:
Christopher Fegan, Chris Pepper, Paul Brennan, Ian Andrew Brewis, Suliman A. Alsagaby, Guy Pratt, Sanjay Khanna, Keith Hart
Publikováno v:
Journal of proteome research. 13(11)
Chronic lymphocytic leukemia (CLL), a malignant B-cell disorder, is characterized by a heterogeneous clinical course. Two-dimensional nano liquid chromatography (2D-nano–LC) coupled with matrix-assisted laser desorption/ionization time-of-flight ta